Dr. Alain Harrus serves as Managing Partner at Impact Science Ventures. He serves as Chairman Emeritus at Kateeva. He served as Venture Advisor at Crosslink Capital. He served as an Advisor at Advanced Micro-Fabrication Equipment. Alain joined Crosslink in 2006 and focuses on venture investments in energy technologies and computing & semiconductors. He has several years of experience in the semiconductor industry as a technologist, senior corporate executive, and investor in high-growth, early-stage companies. Before turning to venture capital, Alain developed breakthrough process technologies that kept semiconductor manufacturers on track with Moore's Law - first as a research scientist at Bell Laboratories, later as chief technical officer at Novellus Systems, and now part of Lam Research (NASD: LRCX). Here he championed a total copper metallization solution for advanced semiconductor manufacturing - a disruptive move that made Novellus a category leader and helped catapult the company across the $1 billion revenue threshold. Prior to joining Crosslink, Alain co-founded Compass Venture Partners and became a founding investor in Tesla Motors (NASD: TSLA). Other investments include Applied Microstructures, Atherotech (acquired by Behrman Capital), Boxer Cross (acquired by AMAT), Luxim, NuvoMedia (acquired by Gemstar), Photodigm, RF Therapeutics (acquired by Boston Scientific), Ripfire (acquired by BEA/ORCL), SoloPower, Torrex Equipment Corp. (acquired by AMAT), and Twin Creeks Technologies. He serves as the Board Member at Intematix. Alain has authored and co-authored more than 30 technical papers, is a co-inventor on six patents, and frequently presents at international conferences. He is a Board Member at Alta Devices. He serves as Board Member at Neutron Therapeutics. He also serves as Board Member at Pixelligent Technologies.